Transformation and creation of engineered tobacco plants expressing a recombinant variant of ligand Protein A

Solar Grants Biotechnology (SGB), based in London, Ontario, focuses on producing various recombinant proteins using engineered tobacco plants as the production platform. Conventional use of stationary bioreactors (fermenters) growing bacterial, yeast, insect or mammalian cells to synthesize recombinant proteins often render the products prohibitively expensive, thus restricting usage and limiting their availability in the developing world. Those significant economic constraints can be alleviated by utilizing engineered photosynthesizing plants as scalable, cost-effective, ecologically friendly bioreactors, thus helping to establish ample supply, expand applications, and deliver novel products to markets. With this project SGB is inclined to develop novel plant bioreactor lines for production of several high-value recombinant proteins for use in biotechnology / pharmaceutical / textile industries.

Faculty Supervisor:

Pieter Anborgh;Ishan Rastogi

Student:

Partner:

Solar Grants Biotechnology Inc.

Discipline:

Life Sciences

Sector:

Manufacturing

University:

Fanshawe College of Applied Arts and Technology

Program:

Business Strategy Internship

Current openings

Find the perfect opportunity to put your academic skills and knowledge into practice!

Find Projects